研討日期	2020年5月18日上午10:20~ 12:30
研討地點	國立臺灣大學609討論室
主講題目 Title of the paper	Optimal price regulations in international pharmaceutical markets with generic competition
作者 Authors of the paper	Difei Geng, Kamal Saggi
文獻出處 Journal, vol.(issue), pp	Journal of Health Economics Volume 71, May 2020, 102315
主講人	Dong Van Chung
參加人員	Dong Van Chung、王羿傑、林燕淑、施姵全、梁文榮、張瑞雲、彭正浩、黃鴻、周宗翰、許至乙、BUI DANG LONG、DAMIANA SIMANJUNTAK
摘要 Abstract of the paper	In a two-country (home and foreign) model in which the home producer of a branded pharmaceutical product faces generic competition in each market, we analyze home's optimal policy choices regarding two major types of price regulations: external reference pricing (ERP) and direct price controls. Home's nationally optimal ERP policy lowers domestic price while maintaining the firm's export incentive. This ERP policy results in a negative international price spillover that the foreign country can (partly) offset via a local price control. Generic competition in either market reduces home's welfare gain from instituting an ERP policy. Weaker competition abroad or a greater weight on firm profits relative to consumer surplus in home's welfare function makes it more likely that home prefers an ERP policy to a price control. While international integration of national generic markets can improve welfare, such is not the case if it causes home to relax its ERP policy.